Patent · US Active

End effector including an implantable arrangement

US10258330B2 · kind B2 · utility

854Cited by
3,972References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2015
Grant dateApr 16, 2019
Priority date
Expiry dateFeb 24, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2017/2937
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

In various embodiments, an end effector comprising a first jaw, a second jaw, an implantable arrangement, first cavities, and second cavities is disclosed. At least one of the first and second jaws is movable to compress tissue between the first jaw and second jaws. The implantable arrangement comprises a first layer and a second layer. The first layer and the second layer comprise a polymeric composition. The first cavities are defined in the first layer and interconnectedly form a permeable first layer. The first cavities releasably retain a first therapeutic agent configured to induce a first biological response in the tissue. The second cavities are defined in the second layer and interconnectedly form a permeable second layer. The second cavities releasably retain a second therapeutic agent configured to induce a second biological response in the tissue. The first therapeutic agent and the second therapeutic agent are different.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.